Black Box Warning Added About Side Effects of Exjade

The FDA has announced that it is requiring a new “black box” warning to alert patients to the potential dangers of Exjade side effects, an iron-reducing medication made by Novartis AG, which could increase the risk of kidney problems, liver problems and gastrointestinal bleeding.

According to a statement posted Thursday on the FDA MedWatch website, the new label will contain a boxed warning indicating that Exjade may cause renal impairment, including kidney failure, hepatic impairment, including liver failure, and gastrointestinal hemorrhage. Among some reported cases, these problems with Exjade were fatal.

The warnings come approximately five months after the FDA issued an early communication in September 2009 to alert healthcare professionals that they were reviewing the potential side effects of Exjade.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Exjade (deferasirox) is an iron chelating medication manufactured by Novartis for people with chronic anemia and iron overload due to a blood transfusion. It was approved by FDA in November 2005, and generated $531 million in sales in 2008.

In 2007, the FDA warned that the drug could cause kidney failure and had resulted in at least eight deaths. The drug’s warning label was subsequently updated to include risks of kidney failure, blood vessel inflammation, hives, and hypersensitivity.

In the most recent safety review, the FDA looked at adverse event data for Exjade and data from a global safety database. The agency concluded that that older patient suffering from myelodysplastic syndrome (MDS) may face a greater risk when compared to younger patients with other chronic anemias.

MDS is a disorder where the patient’s bone marrow does not create enough normal blood cells, resulting in anemia. Those with MDS often need regular blood transfusions, which can cause a buildup of iron in the blood known as iron overload. Iron overload can cause damage to the heart, liver and other organs.

The new warning suggests that doctors closely monitor patients taking Exjade. In particular, they should watch for changes in creatinine levels, as well as changes in the levels of transaminases and bilirubin.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims
Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims (Posted 2 days ago)

Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states